Detrol tablets have been approved for the treatment of overactive bladder.
Results from three placebo-controlled, 12-week studies including almost 2,000 adult patients with overactive bladder symptoms showed a significant reduction, 15 to 21% in the median number of urinations per 24 hours, a significantly greater reduction than the change in placebo patients. In addition, incontinence episodes decreased by 50 to 56% from baseline in treated patients.
The Detrol (tolterodine tartrate) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.